| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2008;118:607-608.)
© 2008 American Heart Association, Inc.
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Prevention of Ventricular Arrhythmias With Sarcoplasmic Reticulum Ca2+ ATPase Pump Overexpression in a Porcine Model of Ischemia Reperfusion |
|---|
Tumor Necrosis Factor- and Mortality in Heart Failure: A Community Study
|
|---|
(TNF
), an inflammatory cytokine, has previously been reported to be elevated in heart failure clinical trial patients with reduced ejection fraction and associated with increased mortality. However, data on patients with preserved EF and those living in the community were lacking. Among community heart failure patients with both preserved and reduced ejection fraction, our study findings indicate that TNF
is elevated in 29% of patients and that higher levels are more common in patients with increased comorbidity, including renal insufficiency and anemia. Higher
Related Articles:
Circulation 2008 118: 658-666.
Circulation 2008 118: 632-638.
and Mortality in Heart Failure: A Community Study
Circulation 2008 118: 625-631.
Circulation 2008 118: 649-657.
Circulation 2008 118: 667-671.
Circulation 2008 118: 639-648.
Circulation 2008 118: 614-624.
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |